Capital Market Strategies’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$232K	Sell	3,627 -100	-3%	-$6.19K	0.16%	120
2025 Q1	$236K	Hold	3,727	–	–	0.16%	120
2024 Q4	$248K	Hold	3,727	–	–	0.14%	130
2024 Q3	$260K	Sell	3,727 -50	-1%	-$3.46K	0.16%	124
2024 Q2	$245K	Hold	3,777	–	–	0.15%	129
2024 Q1	$244K	Hold	3,777	–	–	0.19%	119
2023 Q4	$249K	Buy	3,777 +100	+3%	+$5.81K	0.22%	121
2023 Q3	$205K	Hold	3,677	–	–	0.2%	130
2023 Q2	$225K	Buy	+3,677	New	+$229K	0.21%	122
2023 Q1	–	Sell	-3,677	Closed	-$233K	–	104
2022 Q4	$233K	Hold	3,677	–	–	0.25%	109
2022 Q3	$217K	Hold	3,677	–	–	0.24%	113
2022 Q2	$212K	Hold	3,677	–	–	0.22%	127
2022 Q1	$228K	Sell	3,677 -1,050	-22%	-$64.1K	0.2%	131
2021 Q4	$337K	Buy	+4,727	New	+$342K	0.28%	91